Aspen Pharmacare and Africa CDC are negotiating a multi-year framework to produce hundreds of millions of vaccine doses annually. The deal targets the 1 billion doses consumed across the continent each year, where imports currently meet nearly all demand. Localized production secures supply chains and reduces the continent's vulnerability to global shortages seen during the pandemic.

Scaling Local Capacity to 100 Million Doses